Literatur
Gross G, Pfister H (2004) Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol 193:35–44
Porter WM, Francis N, Hawkins D, Dinneen M, Bunker CB (2002) Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases. Br J Dermatol 147:1159–1165
Kreuter A, Brockmeyer NH, Weissenborn SJ et al (2008) Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. J Invest Dermatol 128:2316–2324
Velazquez EF, Chaux A, Cubilla AL (2012) Histologic classification of penile intraepithelial neoplasia. Semin Diagn Pathol 29:96–102
Bernard HU (2013) Taxonomy and phylogeny of papillomaviruses: an overview and recent developments. Infect Genet Evol 18:357–361
Bouvard V, Baan R, Straif K et al (2009) A review of human carcinogens – part B: biological agents. Lancet Oncol 10:321–322
Wieland U, Kreuter A (2015) HPV-induced anal lesions. Hautarzt 66:439–445
Kreuter A, Siorokos C, Oellig F, Silling S, Pfister H, Wieland U (2016) High-grade dysplasia in anogenital warts of HIV-positive men. JAMA Dermatol 152(11):1225–1230
Gross GE, Werner RN, Becker JC et al (2018) S2k guideline: HPV-associated lesions of the external genital region and the anus – anogenital warts and precancerous lesions of the vulva, the penis, and the peri- and intra-anal skin (short version). J Dtsch Dermatol Ges 16:242–255
Brotherton JM, Ogilvie GS (2015) Current status of human papillomavirus vaccination. Curr Opin Oncol 27:399–404
Castle PE, Maza M (2016) Prophylactic HPV vaccination: past, present, and future. Epidemiol Infect 144:449–468
Kreimer AR, Struyf F, Del Rosario-Raymundo MR et al (2015) Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials. Lancet Oncol 16:775–786
Giuliano AR, Palefsky JM, Goldstone S et al (2011) Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 364:401–411
Palefsky JM, Giuliano AR, Goldstone S et al (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 365:1576–1585
Joura EA, Giuliano AR, Iversen OE et al (2015) A 9‑valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 372:711–723
Castellsague X, Giuliano AR, Goldstone S et al (2015) Immunogenicity and safety of the 9‑valent HPV vaccine in men. Vaccine 33:6892–6901
RKI (Hrsg) (2018) Empfehlungen der Ständigen Impfkommission (STIKO) beim Robert Koch-Institut – 2018/2019. Epidemiologisches Bulletin 34
Schiller J, Lowy D (2018) Explanations for the high potency of HPV prophylactic vaccines. Vaccine 36:4768–4773
Colberg C, van der Horst C, Jünemann KP et al (2018) Epidemiology of penile cancer. Urologe A 57:408–412
Giuliano AR, Nyitray AG, Kreimer AR et al (2015) EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer 136:2752–2760
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Kreuter hat Referentenhonorare von Sanofi Pasteur MSD und MSD SHARP & DOHME erhalten und war im Advisory Board von Sanofi Pasteur MSD und MSD SHARP & DOHME tätig. F. Oellig, S. Silling und U. Wieland geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.
The supplement containing this article is not sponsored by industry.
Additional information
Redaktion
E. von Stebut, Köln
Redaktionelle Mitarbeit
M. Fabri, Köln
C. Sunderkötter, Halle
Rights and permissions
About this article
Cite this article
Kreuter, A., Oellig, F., Silling, S. et al. 69/m mit weißen, nicht abwischbaren Plaques am Penis. Hautarzt 70 (Suppl 1), 2–6 (2019). https://doi.org/10.1007/s00105-018-4317-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-018-4317-0